Skip to main content
. 2020 Nov 1;93(4):2141–2148. doi: 10.1002/jmv.26599

Figure 2.

Figure 2

Overall progression‐free interval in patients with mild to moderate COVID‐19. Significant differences were found in the progression‐free interval between patients stratified by statin use, LDH levels and eGFRs at admission. COVID‐19, coronavirus disease‐2019; eGFR, estimated glomerular filtration rate; LDH, lactate dehydrogenase